Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single molecule protein analysis platform, today announced it will repo

Nautilus BiotechnologyApr 11 00:00 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 289.1% to $18.48 during Friday's pre-market session. The market value of their outstanding shares is at $14.8 million. Xilio Therapeutics (NASDAQ:XLO

BenzingaMar 29 08:06 ET

Nautilus Biotechnology(NAUT.US) 10% Shareholder Buys US$41,477.85 in Common Stocks

$Nautilus Biotechnology(NAUT.US)$ 10% Shareholder Patel Sujal M purchased 14,474 shares of Common Stocks on Mar 8, 11, 2024 at an average price of $2.8657 for a total value of $41,477.85.Source: Annou

moomoo NewsMar 11 21:01 ET

This Nautilus Biotechnology Insider Increased Their Holding In The Last Year

Yahoo FinanceMar 11 07:07 ET

Sujal Patel Buys Handful Of Shares In Nautilus Biotechnology

Even if it's not a huge purchase, we think it was good to see that Sujal Patel, the Co-Founder of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) recently shelled out US$99k to buy stock, at US$2.79 per sh

Simply Wall StMar 11 06:00 ET

Nautilus Biotechnology(NAUT.US) 10% Shareholder Buys US$99,054.42 in Common Stocks

$Nautilus Biotechnology(NAUT.US)$ 10% Shareholder Patel Sujal M purchased 35,526 shares of Common Stocks on Mar 5, 6, 7, 2024 at an average price of $2.7882 for a total value of $99,054.42.Source: Ann

moomoo NewsMar 7 19:49 ET